SCREEN TEST ZIKA

Ns1 Zika Rapid Test – Product code: SC-0760-40

The NS1 Zika rapid test (Whole Blood/Serum/Plasma) is a rapid immunochromatographic test for the qualitative detection of NS1 antigen of the Zika virus in whole blood, serum or human plasma, an adjunct to the diagnosis of Zika infections. The Zika virus (ZIKV) is a member of the Flaviviridae family of viruses. It is spread through daytime active Aedes mosquitoes, such as A. aegypti and A. albopictus. The name comes from the Zika forest in Uganda, where the virus was first isolated in 1947. The Zika virus (ZIKV) is a member of the Flaviviridae family of viruses. It is spread through daytime active Aedes mosquitoes, such as A. aegypti and A. albopictus. The name comes from the Zika forest in Uganda, where the virus was first isolated in 1947. The Zika virus is linked to dengue, yellow fever, Japanese encephalitis and West Nile viruses. Since the 1950s it has been known to spread in the area of ​​the equatorial strip from Africa to Asia. From 2007 to 2016, the virus spread eastward across the Pacific Ocean to America, causing a Zika virus outbreak in 2015-16. The infection, known as Zika fever or Zika virus, often has mild or no symptoms, similar to a very mild form of dengue fever [1]. While there is no specific therapy, acetaminophen (acetaminophen) and rest can help relieve symptoms [3]. As of 2016, the disease cannot be prevented with medicines or vaccines [3]. Zika can also spread from a pregnant woman to her fetus. This can cause microcephaly, severe brain malformations and other birth defects [4] [5]. Zika infections in adults can rarely cause Guillain – Barré syndrome. The Zika NS1 rapid test (Whole Blood/Serum/Plasma) is a rapid test that uses a combination of colored particles coated with Zika NS1 antibodies for the detection of the Zika NS1 antigen in human whole blood, serum or plasma. The Zika NS1 rapid test (Whole Blood/Serum/Plasma) is a qualitative membrane-based immunoassay for the detection of the Zika NS1 antigen in whole blood, serum or plasma. During testing, the sample reacts with the Zika NS1 antibody conjugate on the device. The antibody gold conjugate binds to the Zika NS1 antigen in the sample which by reaction will bind to the Anti-Zika NS1 on the membrane. As the reagent moves across the membrane, the Zika NS1 antibody on the membrane will bind to the antibody-antigen complex causing the formation of a red or pink line in the test area on the membrane. The intensity of the lines will vary depending on the amount of antigen present in the sample. The appearance of a pink line in the test area should be considered a positive result.